News and Views
Nature Medicine 15, 993 - 994 (2009)
doi:10.1038/nm0909-993
Blocking the path of lymphatic vessels
- Mihaela Skobe is in the Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York, USA.
- Reza Dana is at the Schepens Eye Research Institute and Massachusetts Eye and Ear, Harvard Medical School Department of Ophthalmology, Boston Massachusetts, USA.
Correspondence to: Mihaela Skobe1 e-mail: mihaela.skobe@mssm.edu
Abstract
Identification of an endogenous inhibitor of lymphatic vessel formation provides a glimpse at how lymphatic vessel growth is restrained (pages 1023–1030). The findings might be exploited to lower transplant rejection rates.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Splitting vessels: Keeping lymph apart from bloodNature Medicine News and Views (01 Feb 2003)
Genes tell lymphatics to sprout or notNature Immunology News and Views (01 Jan 2004)
See all 3 matches for News And ViewsRESEARCH
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine Article (01 Sep 2009)
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunityNature Medicine Brief Communication (01 Aug 2004)
See all 49 matches for Research
